Experiencia en hemodiafiltración en línea de alto volumen: Un estudio longitudinal de 47 meses de seguimiento en Ecuador

Introduction: High-volume online hemodiafiltration (OL-HDF) offers clinical benefits concerning high-flux hemodialysis (HF-HD) in removing medium molecular weight solutes. The OL-HDF program in Fresenius Clinics Medical Care del Ecuador (FMC-E) began in September 2018. This study aimed to determine the main epidemiological, clinical, and hospitalization parameters in the HDF-OL program and compare them with HD-AF patients. Methods: The present longitudinal study was carried out in the statistics department of FMC-E from September 3, 2018, to July 30, 2022. Patients receiving renal replacement therapy with >90 days in the hemodialysis program were included. Two groups were formed, the first with HD-AF patients and HDF-OL patients. The variables were demographic, clinical, laboratory, and therapeutic. The source was the EuCLID computer system. The sample was non-probabilistic. Non-inferential and inferential statistics are used. Results: 3653 patients in HD-AF and 1170 patients in HDF-OL were analyzed. The age of 53.1 years. 5.4 days of hospitalization/patient/year in the HD-AF group and 3.4 in the HDF-OL group ( P